State Street Amends Cytokinetics Stake, Signals Institutional Holdings
Ticker: CYTK · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals
TL;DR
**State Street updated its Cytokinetics holdings, confirming continued institutional interest.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership in Cytokinetics Inc. as of December 31, 2023. This filing updates their previous disclosure regarding their holdings of Cytokinetics' common stock. For investors, this matters because State Street is a significant institutional investor, and changes in their reported ownership can signal shifts in institutional sentiment or investment strategy towards Cytokinetics.
Why It Matters
This filing shows that a large institutional investor, State Street Corporation, continues to hold a position in Cytokinetics, which can be a vote of confidence or a routine disclosure of their managed assets.
Risk Assessment
Risk Level: low — This is a routine amendment by a large institutional investor and does not inherently signal significant risk or opportunity.
Analyst Insight
An investor should note that State Street Corporation continues to hold a position in Cytokinetics, but this filing alone doesn't provide details on the size or change in their stake, so further investigation into the full filing's details would be necessary for actionable insights.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Cytokinetics Inc. (company) — the subject company whose common stock is being reported
- 0000093751-24-000224 (dollar_amount) — accession number for the filing
- December 31, 2023 (date) — date of event which requires filing of this statement
- January 25, 2024 (date) — date the filing was made
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'AMENDED FILING' sections.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORPORATION, as clearly identified under 'NAME OF REPORTING PERSON: STATE STREET CORPORATION'.
What is the subject company whose securities are being reported?
The subject company is CYTOKINETICS INC, as indicated under 'NAME OF ISSUER: CYTOKINETICS INC'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the common stock of Cytokinetics Inc. is 23282W605, as stated in the 'CUSIP NUMBER' section.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under 'DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding CYTOKINETICS INC (CYTK).